Bakgrunn og aktiviteter
- dr. philos. medisinsk statistikk, UiO, 1990
- cand. pharm. UiO, 1985
- anvendt statistikk
- statistiske metoders egenskaper
- klinisk kreftforskning
- kontrollerte kliniske forsøk
- dokumentasjon av nye legemidlers effekt og sikkerhet
Styrer og råd
- Styremedlem Kreftregisteret
- Varamedlem i den Nasjonale forskningsetiske komité for medisin og helsefag (NEM)
- Medlem styringsgruppe NORCCAP (NORwegian Colorectal Cancer Prevention)
- Medlem editorial board, Scandinavian Journal of Pain
Vitenskapelig, faglig og kunstnerisk arbeid
Et utvalg av nyere tidsskriftspublikasjoner, kunstneriske produksjoner, bok, inklusiv bokdeler og rapport-del. Se alle publikasjoner i databasen
- (2019) What should be the preferred exercise modality for overweight and obese individuals? Protocol for a systematic review and network meta-analysis. Systematic Reviews. vol. 8 (41).
- (2019) Second cancers in radically treated Norwegian prostate cancer patients. Acta Oncologica. vol. 58 (6).
- (2019) EBV-requisitioning physicians' guess on fatigue state 6 months after acute EBV infection. BMJ Paediatrics Open. vol. 3 (1).
- (2019) Agreement between self-reported and registry-based use of sleep medications and tranquilizers. Pharmacoepidemiology and Drug Safety. vol. 28 (10).
- (2019) Presenting complaints and mortality in a cohort of 22 000 adult emergency patients at a local hospital in Nepal. Journal of Global Health. vol. 9 (2).
- (2019) Continuous development of colorectal cancer screening programs. Acta Oncologica. vol. 3 (1).
- (2019) The Oslo Study of Clonidine in Elderly Patients with Delirium; LUCID: a randomised placebo-controlled trial. International Journal of Geriatric Psychiatry. vol. 34 (7).
- (2019) Paediatric goal management training in patients with acquired brain injury: study protocol for a randomised controlled trial. BMJ Open. vol. 9:e029273 (8).
- (2019) Comparative effectiveness of warfarin, dabigatran, rivaroxaban and apixaban in nonvalvular atrial fibrillation: A nationwide pharmacoepidemiological study. PLOS ONE. vol. 14 (8).
- (2019) Clinical symptoms and markers of disease mechanisms in adolescent chronic fatigue following Epstein-Barr virus infection: An exploratory cross-sectional study. Brain, behavior, and immunity. vol. 80.
- (2019) Prevalence and risk factors of drug-related hospitalizations in multimorbid patients admitted to an internal medicine ward. PLOS ONE. vol. 14 (7).
- (2019) Fatigue in Epstein-Barr virus infected adolescents and healthy controls: A prospective multifactorial association study. Journal of Psychosomatic Research. vol. 121.
- (2019) Lifestyle factors during acute Epstein-Barr virus infection in adolescents predict physical activity six months later. Acta Paediatrica. vol. 108 (8).
- (2019) Neuropsychological dysfunction in chronic fatigue syndrome and the relation between objective and subjective findings. Neuropsychology. vol. 33 (5).
- (2019) Effect of clinical geriatric assessments and collaborative medication reviews by geriatrician and family physician for improving health-related quality of life in home-dwelling older patients receiving polypharmacy: a cluster randomized clinical trial. JAMA Internal Medicine.
- (2018) Does Prophylactic Radiation Therapy to Avoid Gynecomastia in Patients With Prostate Cancer Increase the Risk of Breast Cancer?. International Journal of Radiation Oncology, Biology, Physics. vol. 101 (1).
- (2018) Systemix exertion intolerance disease diagnostic criteria Applied on an adolescent chronic fatigue syndrom cohort: evaluation of subgroup differences and prognostic utility. BMJ Paediatrics Open. vol. 2.
- (2018) Association between vascular comorbidity and progression of Alzheimer's disease: a two-year observational study in Norwegian memory clinics. BMC Geriatrics. vol. 18:120.
- (2018) Impact of body weight, low energy diet and gastric bypass on drug bioavailability, cardiovascular risk factors and metabolic biomarkers: protocol for an open, non-randomised, three-armed single centre study (COCKTAIL). BMJ Open. vol. 8:e021878 (5).
- (2018) Anti-osteoporosis drug use: too little, too much, or just right? The HUNT study, Norway. Osteoporosis International. vol. 29 (8).